These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Clinical effect of the spasmolytic agent hyoscine N-butylbromide (buscopan) in so-called spastic bronchitis in infants]. GADEKE R Kinderarztl Prax; 1955 Nov; 23(11):486-92. PubMed ID: 13279076 [No Abstract] [Full Text] [Related]
24. Angioneurotic oedema and urticaria induced by hyoscine butylbromide. Robinson AC; Teeling M Postgrad Med J; 1982 May; 58(679):316. PubMed ID: 7111123 [TBL] [Abstract][Full Text] [Related]
25. A comparison of the value of hyoscine butylbromide and glucagon on aorto iliac intravenous digital subtraction. Rowland-Hill CA; Loveday EJ; Thomas ML Vasa; 1989; 18(4):301-3. PubMed ID: 2609736 [TBL] [Abstract][Full Text] [Related]
29. Echocardiographic evaluation of vagolytic effects of hyoscine butylbromide in paediatric halothane anaesthesia. Yamashita M; Horigome H Agressologie; 1989 Sep; 30(8):489-91. PubMed ID: 2610296 [TBL] [Abstract][Full Text] [Related]
30. Letter: Rebound effect of hyoscine butylbromide on postoperative bowel contractions. Fry EN; Deshpande S Br Med J; 1976 Mar; 1(6010):646-7. PubMed ID: 1252864 [No Abstract] [Full Text] [Related]
31. [Sonographic study of the effect of hyoscin-N-butylbromide on cholecystokinin stimulated gallbladder motility]. Wagner T; Botzler R; Ritter U Z Gastroenterol; 1984 Jun; 22(6):305-10. PubMed ID: 6464523 [TBL] [Abstract][Full Text] [Related]
33. Oral hyoscine butylbromide does not alter the pattern of small intestinal motor activity. Thompson DG; Wingate DL Br J Pharmacol; 1981 Apr; 72(4):685-7. PubMed ID: 7284686 [TBL] [Abstract][Full Text] [Related]
34. Prophylactic Scopolamine Butylbromide and Death Rattle in Patients at the End of Life. Abe A; Amano K; Ishiki H JAMA; 2022 Jan; 327(3):285. PubMed ID: 35040894 [No Abstract] [Full Text] [Related]
35. Prophylactic Scopolamine Butylbromide and Death Rattle in Patients at the End of Life-Reply. van Esch HJ; van Zuylen L; van der Rijt CCD JAMA; 2022 Jan; 327(3):285-286. PubMed ID: 35040890 [No Abstract] [Full Text] [Related]
36. Prophylactic scopolamine butylbromide reduced death rattle in patients in the dying phase. Mechineni A Ann Intern Med; 2022 Mar; 175(3):JC31. PubMed ID: 35226526 [TBL] [Abstract][Full Text] [Related]
37. Dose-response relationships of intravenous hyoscine butylbromide and atropine sulphate on heart rate in healthy volunteers. Grainger SL; Smith SE Br J Clin Pharmacol; 1983 Dec; 16(6):623-6. PubMed ID: 6661345 [TBL] [Abstract][Full Text] [Related]
38. [Effect of imecromone and hyoscine N-butylbromide in endoscopic cholangiopancreatography]. Garbarini A; Foco A; Serenthà U; Enrichens F; Mao P; Rossetti F Minerva Chir; 1986 Jan; 41(1-2):45-50. PubMed ID: 3703309 [No Abstract] [Full Text] [Related]
39. The value of hyoscine butylbromide in aorto-iliac intravenous digital subtraction angiography. Bennett C; Phillips GW; Colthurst JR; Lea Thomas M Vasa; 1987; 16(3):262-4. PubMed ID: 3310446 [No Abstract] [Full Text] [Related]
40. [Comparison of effectiveness of 4-methylumbelliferone and hyoscine-N-butylbromide in therapy following biliary tract surgery]. Fischer D; Krumme H Med Welt; 1980 Jun; 31(23):894-7. PubMed ID: 6775170 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]